2Nilsson B,Bumming P,Meis-Kindblom JM,et al.Gastrointestinal stromal tumors:the incidence,prevalence,clinical course,and prognostication in the preimatinib mesylate era-apopulation-based study in Western Sweden[J].Cancer,2005,103(4):821-829.
3DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:Recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231(1):51-58.
4Miettinen M,Kopczynski J,Makhlouf HR,et al.Gastrointestinal stromal tumor,intramural leiomyomas,and leiomyosarcomas in the duodenum:a clinicopathologic,immumohistochemical,and molecular genetic study of 167 cases[J].Am J Surg Pathol,2003,27(5):625-641.
5Miettinen M,Sobin LH,Sarlomo-Riskala M.Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT)[J].Mod Pathol,2000,13(10):1134-1142.
6Miettinen M,Sobin LH,Lasota J,et al.Gastrointestinal stromal tumors of the stomach:A clinicopathologic,immunohistochemical,and molecular genetic study of 1765 cases with long-term follow-up[J].Am J Surg Pathol,2005,29(1):52-68.
7Miettinen M,el-Rifai W,Sobin L,et al.Evaluation of malignancy and prognosis of gastrointestinal stromal tumors:A review[J].Hum Pathol,2002,33(5):478-483.
8Goldblum JRC.DNA ploidy and proliferative index in gastrointestinal stromal tumors[J].Hum Pathol,1998,29(1):102.
10Lasota J,Jasinski M,Sarlomo-Rikala M,et al.Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas[J].Am J Pathol,1999,154(1):53-60.
